On Thursday, our Under the Radar Movers�newsletter suggested shorting small cap rare disease stock Abeona Therapeutics Inc (NASDAQ: ABEO):
��Abeona Therapeutics is clearly a timing trade - we think today's something of a blowoff top, marked by a volume surge and the fact that the stock's already peeling back from its peak; the profit-takers are already going to work. We saw a similar surge on Tuesday, and though that one didn't end up kick-starting a pullback, it helped set up today's reversal bar (by virtue of luring in the last of the would-be buyers). There's just not a lot of room left for more upside.��
Our Under the Radar Movers�newsletter has a more detailed discussion about Abeona Therapeutics Inc��s technical chart along with an appropriate short/bearish strategy:
Hot Small Cap Stocks To Buy For 2019: eBay Inc.(EBAY)
Advisors' Opinion:- [By Motley Fool Staff]
Lewis: It must have been in the late 90s. My mom was super into eBay�(NASDAQ:EBAY) back then, and I was a pretty avid baseball card collector. There were a lot of times where I was trying to get this one specific card, and some guy in Oklahoma was selling it on eBay, so I was involved in the auction. I think that was my early online purchase experience.
- [By Money Morning Staff Reports]
You may have used eBay Inc. (Nasdaq: EBAY) to buy used items. But have you ever considered buying used gold on there as well?
If you're anything like us, then you love finding deals. And there aren't many better places to find good deals than in a peer-to-peer online marketplace like eBay.
- [By Adam Levy]
Amazon (NASDAQ:AMZN) benefited from that rule for a long time, but it eventually expanded its fulfillment center network to the point where it now collects sales tax in every state. Requiring other online retailers to collect sales tax -- including third-party sellers on marketplaces like Amazon's, eBay (NASDAQ:EBAY), or even Walmart's (NYSE:WMT) website -- would actually put Amazon back on equal footing with its biggest competition. What's more, it could make smaller retailers more reliant on Amazon or other services to provide tax collection services, putting them at a further disadvantage.
- [By Todd Campbell, Rich Smith, and Neha Chamaria]
Great stocks that disrupt big markets and reward shareholders with massive long-term returns, such as eBay (NASDAQ:EBAY), don't come around every day, so when they do, investors should consider adding them to their portfolios. These Motley Fool investors think Roku (NASDAQ:ROKU), Raven Industries (NASDAQ:RAVN), and Foundation Medicine (NASDAQ:FMI) fall into that camp. Are they worth buying right now? Read on to learn more about these stocks and what could cause them to deliver envy-inspiring returns in the future.
Hot Small Cap Stocks To Buy For 2019: Blackrock Municipal Bond Trust(BBK)
Advisors' Opinion:- [By Joseph Griffin]
Media coverage about BlackRock Municipal Bond Trust (NYSE:BBK) has been trending somewhat positive recently, Accern Sentiment reports. Accern identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. BlackRock Municipal Bond Trust earned a media sentiment score of 0.25 on Accern’s scale. Accern also gave headlines about the financial services provider an impact score of 47.5280376576675 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
- [By Shane Hupp]
Doliver Capital Advisors LP trimmed its stake in shares of Blackrock Municipal Bond Trust (NYSE:BBK) by 26.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 10,260 shares of the financial services provider’s stock after selling 3,598 shares during the quarter. Doliver Capital Advisors LP owned about 0.10% of Blackrock Municipal Bond Trust worth $147,000 as of its most recent filing with the Securities and Exchange Commission.
Hot Small Cap Stocks To Buy For 2019: Exelixis, Inc.(EXEL)
Advisors' Opinion:- [By Dan Caplinger]
Wall Street had another good session on Thursday, with further gains for major markets as benchmarks like the Russell 2000 index of small-cap stocks flirted with record highs. A favorable reading from the consumer price index showed only modest growth in prices, and the idea that inflation remains in check led market participants to believe that the Federal Reserve won't have to speed up its efforts to return short-term interest rates to more normal levels. Yet even with the overall market picking up ground, some companies had bad news that weighed on their share prices. Booking Holdings (NASDAQ:BKNG), Exelixis (NASDAQ:EXEL), and L Brands (NYSE:LB) were among the worst performers on the day. Here's why they did so poorly.
- [By ]
Exelixis (EXEL) : "Biotechs are not working so I'm not going to recommend it."
Moneygram (MGI) : "No, you need quality and this one doesn't have it."
- [By Max Byerly]
BidaskClub upgraded shares of Exelixis (NASDAQ:EXEL) from a strong sell rating to a sell rating in a report released on Friday.
EXEL has been the subject of a number of other research reports. Cann restated a buy rating and set a $40.00 price objective on shares of Exelixis in a research note on Wednesday, May 30th. ValuEngine lowered Exelixis from a sell rating to a strong sell rating in a research note on Friday, May 11th. William Blair reaffirmed a buy rating on shares of Exelixis in a report on Wednesday, April 11th. Oppenheimer raised Exelixis from a market perform rating to an outperform rating and set a $40.00 target price on the stock in a report on Tuesday, February 27th. Finally, Stifel Nicolaus reduced their target price on Exelixis from $30.00 to $29.00 and set a hold rating on the stock in a report on Thursday, May 3rd. Two investment analysts have rated the stock with a sell rating, four have given a hold rating and nine have issued a buy rating to the company’s stock. The company has a consensus rating of Hold and an average price target of $32.80.
- [By Brian Orelli]
After a disappointing fourth quarter, Exelixis (NASDAQ:EXEL) reaccelerated growth in the first quarter, bolstered by a new approval for Cabometyx in previously untreated advanced renal cell carcinoma (RCC), also known as kidney cancer.
No comments:
Post a Comment